BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27296259)

  • 1. [Risk factors for pulmonary hypertension at the predialysis stage of chronic kidney disease].
    Rudenko TE; Vasilyeva MP; Solomakhina NI; Kutyrina IM
    Ter Arkh; 2016; 88(6):33-39. PubMed ID: 27296259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for diastolic left ventricular myocardial dysfunction in patients with chronic kidney disease.
    Rudenko TE; Kamyshova ES; Vasilyeva MP; Bobkova IN; Solomakhina NI; Shvetsov MY
    Ter Arkh; 2018 Sep; 90(9):60-67. PubMed ID: 30701737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cystatin C is a new marker for left ventricular hypertrophy in patients with chronic kidney disease].
    Vasilyeva MP; Rudenko TE; Kutyrina IM; Solomakhina NI
    Ter Arkh; 2015; 87(6):17-22. PubMed ID: 26281190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy.
    Vickery S; Price CP; John RI; Abbas NA; Webb MC; Kempson ME; Lamb EJ
    Am J Kidney Dis; 2005 Oct; 46(4):610-20. PubMed ID: 16183415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [B-type natriuretic peptide as a marker of cardiac dysfunction in children with chronic kidney disease].
    Drożdż T; Kwinta P; Kordon Z; Sztefko K; Rudziński A; Zachwieja K; Miklaszewska M; Czarnecka D; Drożdż D
    Pol Merkur Lekarski; 2018 Apr; 44(262):171-176. PubMed ID: 29775443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creatinine- vs. cystatin C-based equations compared with 99mTcDTPA scintigraphy to assess glomerular filtration rate in chronic kidney disease.
    Trimarchi H; Muryan A; Martino D; Toscano A; Iriarte R; Campolo-Girard V; Forrester M; Pomeranz V; Fitzsimons C; Lombi F; Young P; Raña MS; Alonso M
    J Nephrol; 2012; 25(6):1003-15. PubMed ID: 22322818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C: a potential biomarker for pulmonary arterial hypertension.
    Fenster BE; Lasalvia L; Schroeder JD; Smyser J; Silveira LJ; Buckner JK; Brown KK
    Respirology; 2014 May; 19(4):583-9. PubMed ID: 24628703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
    Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension in patients with stage 1-3 chronic kidney disease.
    Yang QM; Bao XR
    Genet Mol Res; 2014 Jul; 13(3):5695-703. PubMed ID: 25117327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cystatin C level is associated with left atrial enlargement, left ventricular hypertrophy and impaired left ventricular relaxation in patients with stage 2 or 3 chronic kidney disease.
    Sakuragi S; Ichikawa K; Yamada K; Tanimoto M; Miki T; Otsuka H; Yamamoto K; Kawamoto K; Katayama Y; Tanakaya M; Ito H
    Int J Cardiol; 2015; 190():287-92. PubMed ID: 25932809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between N-terminal pro-B-type natriuretic peptide plasma levels and renal function evaluated with different formulae in older adult subjects admitted because of dyspnea.
    Fabbian F; De Giorgi A; Portaluppi F; Zuliani G
    Gerontology; 2012; 58(1):50-5. PubMed ID: 21540563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of malnutrition, N-terminal pro-B-type natriuretic peptide and ventricular remodeling in patients on maintenance hemodialysis.
    Lee YJ; Song BG; Kim MS; Cho S; Chun WJ; Oh JH; Kim SR
    Clin Nephrol; 2013 Apr; 79(4):253-60. PubMed ID: 23149248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between glomerular filtration rate and plasma N-terminal pro B-type natriuretic peptide concentrations in dogs with chronic kidney disease.
    Miyagawa Y; Tominaga Y; Toda N; Takemura N
    Vet J; 2013 Aug; 197(2):445-50. PubMed ID: 23570775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
    Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
    Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes.
    Sawada R; Hashimoto Y; Senmaru T; Tanaka M; Ushigome E; Yamazaki M; Fukui M
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):590-595. PubMed ID: 29697035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension.
    Blyth KG; Groenning BA; Mark PB; Martin TN; Foster JE; Steedman T; Morton JJ; Dargie HJ; Peacock AJ
    Eur Respir J; 2007 Apr; 29(4):737-44. PubMed ID: 17135228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency.
    Harbaum L; Hennigs JK; Baumann HJ; Lüneburg N; Griesch E; Bokemeyer C; Grünig E; Klose H
    PLoS One; 2014; 9(4):e94263. PubMed ID: 24751887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between levels of sex hormones and response to cardiac resynchronisation therapy in men].
    Enina TN; Kuznetsov VA; Soldatova AM; Petelina TI; Krinochkin DV; Dyachkov SM; Rychkov AY; Gorbunova TY
    Kardiologiia; 2018 SJul; 58(S7):24-35. PubMed ID: 30081800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.